• COMPANY

    Vantage BioTrials Inc. is a privately-held, Contract Research Organization (CRO) that provides Phase I-IV clinical trial management services to international pharmaceutical, biotechnology, generic pharmaceutical and medical device companies.

  • LEADERSHIP

    Vantage BioTrials has become a leader in providing clinical trial management services by implementing Quality by Design (QbD) strategies, Risk-Based Approaches to Monitoring and process improvement methods to the entire clinical trial lifespan.

  • AWARDS

    Vantage BioTrials’ level of quality service has been a distinguishing factor over the years as we are continually challenging ourselves to achieve goals beyond our ability.  As proof, we’ve had the honor of being the recipient of several notable awards and accomplished numerous milestones.

Latest News

Events

White Papers See All

Analysis of Highlights from Health Canada’s GCP Inspection Results in 2016
Publication date: June 2017 / Download as PDF Author: Irina Mosesova Introduction At Vantage BioTrials (VBT) we pride ourselves at continuously learning and keeping up to date with the latest developments in clinical research and compliance issues that can potentially effect trial results or even patient safety. The industry is changing at an incredible rate and in an… Read more
Quality by Design in Clinical Research
In clinical research, “high quality” means that a study generates good, useful data, does not harm the study participants, and proceeds smoothly with few interruptions by errors or omissions. However, too many clinical research studies get mired in a time-consuming quality control (QC) process that generates numerous site monitor findings (e.g., missing data, ineligible study participants, other protocol deviations), data queries, and other after-the-fact indications that a quality problem has been found and needs to be fixed. A research site may be unable to deliver acceptable results, no matter how much the sponsor tries to help. In severe cases, the design of a study incorporates problems that make it impossible to achieve high quality results, no matter how well the study is conducted. Read more
Clinical Trial Management: Houston, We Have a Problem
In the management of clinical trials, whether they be local, international, multi-site, simple or complex, a variety of situations can (or should I say will) occur that will have you saying “Houston, we have a problem!” These complications may be related to an issue at the clinical site itself, within the CRO or at the Sponsor level, but could also be caused by the study protocol or the investigational drug itself. This white paper will present a methodology to optimize clinical trial management by using best practices, as well as how to avoid and resolve problematic situations that may arise throughout the trial. Read more